| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|---|
| 1. | MligTC455_23029 | 200 | 4.16 | Mlig455_043356 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.584/0.02978 |
ABL1 | Mlig455_043356 {REF} {Length: 5848} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=320.1]; Protein kinase domain [PF00069.27, score=153.7]; SH2 domain [PF00017.26, score=78.5]; F-actin binding [PF08919.12, score=34.5]; Variant SH3 domain [PF14604.8, score=20.6]; SH3 domain [PF00018.30, score=18.8]} {Human: ENSG00000097007, ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, [RH, Score=548, Expect=1e-176]; ENSG00000143322, ABL2, ABL proto-oncogene 2, non-receptor tyrosine kinase, [RH, Score=543, Expect=3e-174]} {Mouse: ENSMUSG00000026842, Abl1, c-abl oncogene 1, non-receptor tyrosine kinase, [RH, Score=549, Expect=2e-177]; ENSMUSG00000026596, Abl2, v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene), [RH, Score=538, Expect=9e-174]} {Dmel: FBgn0000017, Abl, Abl tyrosine kinase, [RH, Score=548, Expect=3e-172]} {Celegans: WBGene00000018, abl-1, Tyrosine-protein kinase abl-1, [RH, Score=517, Expect=2e-164]} {Smed: dd_Smed_v6_4352_0_1, dd_Smed_v6_4352_0_1, [RH, Score=555, Expect=0.0]} {RNA1509_21216, RNA1509_50452} {RNA1310_7858, RNA1509_50452} {RNA1509_50452, RNA815_21818} |